TYSABRI® RISK MINIMIZATION ACTION PLAN: SUMMARY OF TOUCHSM

First Page		Document Content
Natalizumab Biogen Idec Pharmacology Medical prescription Progressive multifocal leukoencephalopathy Medicine Health Immunosuppressants		TYSABRI® RISK MINIMIZATION ACTION PLAN: SUMMARY OF TOUCHSM Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 54,89 KB Share Document on Facebook